Skip to main content

Advertisement

Fig. 1 | BMC Women's Health

Fig. 1

From: Pathological profiles and clinical management challenges of breast cancer emerging in young women in Indonesia: a hospital-based study

Fig. 1

Progression free survival correlated to some parameters in YBCs. PFS of YBCs was significantly shorter (a) in YBCs with skin or chest wall infiltration (T4) compared to those without skin/chest wall infiltration (T1-T3) (median survival 16 vs. 35 months, p = 0.011; HR = 1.89, 95%CI: 1.12–3.21); b in YBCs with positive lymph node infiltration compared to node negative (median survival 24 vs 42 months, p = 0.041; HR = 1.95, 95%CI: 1.05–3.64); c in YBC with hormonal receptor positive compared to negative (median survival 42 vs. 29 months, p = 0.37; HR = 1.64, 95%CI: 1.01–2.67), and (d) in triple-negative YBCs compared to other subtypes (median survival 16 vs 38 months, p = 0.038; HR = 1.66, 95%CI: 1.02–2.72)

Back to article page